You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

~ Buy the DYANAVEL XR 20 (amphetamine; amphetamine aspartate/dextroamphetamine sulfate) Drug Profile, 2024 PDF Report in the Report Store ~

DYANAVEL XR 20 Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Dyanavel Xr 20 patents expire, and when can generic versions of Dyanavel Xr 20 launch?

Dyanavel Xr 20 is a drug marketed by Tris Pharma Inc and is included in one NDA. There are four patents protecting this drug.

This drug has twenty-one patent family members in fourteen countries.

The generic ingredient in DYANAVEL XR 20 is amphetamine; amphetamine aspartate/dextroamphetamine sulfate. There are fifty-five drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the amphetamine; amphetamine aspartate/dextroamphetamine sulfate profile page.

DrugPatentWatch® Generic Entry Outlook for Dyanavel Xr 20

Indicators of Generic Entry

< Available with Subscription >

  Try a Trial

Summary for DYANAVEL XR 20
Drug patent expirations by year for DYANAVEL XR 20
Recent Clinical Trials for DYANAVEL XR 20

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Tris Pharma, Inc.Phase 4
Tris Pharma, Inc.Phase 3

See all DYANAVEL XR 20 clinical trials

Pharmacology for DYANAVEL XR 20

US Patents and Regulatory Information for DYANAVEL XR 20

DYANAVEL XR 20 is protected by four US patents.

Patents protecting DYANAVEL XR 20


Patent Number: ⤷  Try a Trial
Patent Expiration: ⤷  Try a Trial
Patented Use: METHOD OF TREATING ATTENTION DEFICIT HYPERACTIVITY DISORDER

Modified release formulations containing drug-ion exchange resin complexes
Patent Number: ⤷  Try a Trial
Patent Expiration: ⤷  Try a Trial

Modified release formulations containing drug-ion exchange resin complexes
Patent Number: ⤷  Try a Trial
Patent Expiration: ⤷  Try a Trial

Modified release formulations containing drug-ion exchange resin complexes
Patent Number: ⤷  Try a Trial
Patent Expiration: ⤷  Try a Trial

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Tris Pharma Inc DYANAVEL XR 20 amphetamine; amphetamine aspartate/dextroamphetamine sulfate TABLET, EXTENDED RELEASE;ORAL 210526-004 Nov 4, 2021 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial Y ⤷  Try a Trial
Tris Pharma Inc DYANAVEL XR 20 amphetamine; amphetamine aspartate/dextroamphetamine sulfate TABLET, EXTENDED RELEASE;ORAL 210526-004 Nov 4, 2021 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial Y ⤷  Try a Trial
Tris Pharma Inc DYANAVEL XR 20 amphetamine; amphetamine aspartate/dextroamphetamine sulfate TABLET, EXTENDED RELEASE;ORAL 210526-004 Nov 4, 2021 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial Y ⤷  Try a Trial
Tris Pharma Inc DYANAVEL XR 20 amphetamine; amphetamine aspartate/dextroamphetamine sulfate TABLET, EXTENDED RELEASE;ORAL 210526-004 Nov 4, 2021 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial Y ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for DYANAVEL XR 20

See the table below for patents covering DYANAVEL XR 20 around the world.

Country Patent Number Title Estimated Expiration
Denmark 2428205 ⤷  Try a Trial
Spain 2378573 ⤷  Try a Trial
Russian Federation 2435569 КОМПОЗИЦИИ С МОДИФИЦИРОВАННЫМ ВЫСВОБОЖДЕНИЕМ, СОДЕРЖАЩИЕ КОМПЛЕКСЫ ЛЕКАРСТВЕННОЕ ВЕЩЕСТВО - ИОНООБМЕННАЯ СМОЛА (COMPOSITIONS WITH MODIFIED RELEASE, CONTAINING COMPLEXES MEDICATION-ION-EXCHANGING RESIN) ⤷  Try a Trial
China 102488652 Modified release formulations containing drug-ion exchange resin complexes ⤷  Try a Trial
China 101400343 Modified release formulations containing drug-ion exchange resin complexes ⤷  Try a Trial
South Korea 101495146 ⤷  Try a Trial
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.